New antibiotic for moderate or severe diabetic foot infections
Treatments studied
Part of Hormones & metabolism, Infections clinical trials.
This Phase 3 trial tests a new medicine (contezolid acefosamil, and contezolid) to treat moderate or severe diabetic foot infections. It compares the new treatment to linezolid to see which works better and is safer for adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diabetes (type 1 or type 2).
- You have a diabetic foot infection that started at or below the ankle and does not go above the knee.
- Your infection is considered moderate or severe (called levels 3 or 4 by an infection guideline).
- Your symptoms started suddenly or got worse within the last 14 days.
- You are not pregnant and not breastfeeding.
- You have not taken contezolid or contezolid acefosamil before, and you should be able to follow the study visits and medicine schedule.
- The infection should not involve bone infection (osteomyelitis) and should not be a very dangerous tissue infection like gangrene or necrotizing fasciitis, and blood flow to the foot should not be so poor that revascularization is needed during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies an approach to treat bacteria living in a diabetic foot ulcer and help prevent the ulcer from coming back. You may be able to join if you have an open diabetic foot ulcer and good blood flow to the wound.
This study tests a new gel applied to infected diabetic foot ulcers. It aims to see if the gel can help the infection and ulcer heal better than standard care.
This trial tests whether adding the VULNOFAST Plus/VULNOLIGHT system to usual care can heal infected diabetic foot ulcers more safely and effectively. It compares the added treatment plus usual care versus usual care alone.
This study tests a new gel treatment (Nu-3) for mild infections in diabetic foot ulcers. The goal is to find the right dose and see if it helps heal these wounds safely.
This study tests a new device that quickly identifies the germs in foot wounds of people with diabetes and bone infections. It may help doctors choose the right antibiotic faster.
This trial tests a new treatment using special skin cells grown into tiny spheres (spheroids) to help heal diabetic foot ulcers that have not healed with standard care. It aims to see if this treatment is safe and works better than usual care.
Hear when a new Diabetic Foot Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.